Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives $22.27 Consensus Target Price from Brokerages

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have earned an average rating of “Hold” from the thirteen ratings firms that are covering the stock, MarketBeat reports. Seven investment analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $22.1667.

A number of equities research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Barclays upped their price objective on Sabra Healthcare REIT from $21.00 to $23.00 and gave the company an “equal weight” rating in a report on Monday, August 31st. Scotiabank decreased their target price on Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Finally, UBS Group set a $25.00 target price on Sabra Healthcare REIT in a report on Wednesday, July 22nd.

Sabra Healthcare REIT Price Performance

SBRA stock opened at $20.78 on Monday. Sabra Healthcare REIT has a 52 week low of $17.17 and a 52 week high of $22.77. The company has a market capitalization of $5.31 billion, a price-to-earnings ratio of 79.93, a price-to-earnings-growth ratio of 1.58 and a beta of 0.65. The firm’s 50-day moving average is $20.61 and its two-hundred day moving average is $20.19. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.95.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The company had revenue of $230.11 million during the quarter, compared to the consensus estimate of $219.39 million. During the same quarter last year, the business earned $0.38 earnings per share. The company’s revenue was up 24.7% on a year-over-year basis. On average, analysts forecast that Sabra Healthcare REIT will post 1.52 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio is currently 461.54%.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of hedge funds have recently modified their holdings of the stock. Rothschild Investment LLC boosted its position in shares of Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 889 shares during the period. Smartleaf Asset Management LLC raised its holdings in Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 714 shares during the period. Versant Capital Management Inc lifted its stake in Sabra Healthcare REIT by 70.0% during the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after buying an additional 603 shares in the last quarter. Strengthening Families & Communities LLC purchased a new stake in Sabra Healthcare REIT during the fourth quarter valued at about $29,000. Finally, Danske Bank A S acquired a new position in shares of Sabra Healthcare REIT in the third quarter worth about $30,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.